Dr. Osama Ea El Silimy, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 73 Sweden Street, Caribou, ME 04736 Phone: 207-492-1377 Fax: 207-492-1376 |
News Archive
Bayer HealthCare announced today that the New Drug Application for its oral investigational compound riociguat has been accepted for filing and granted priority review by the U.S. Food and Drug Administration for the treatment of inoperable chronic thromboembolic pulmonary hypertension or with persistent or recurrent CTEPH after pulmonary endarterectomy and pulmonary arterial hypertension.
Quitting methamphetamine use can reverse the damage the drug causes to the heart and improve heart function in abusers when combined with appropriate medical treatment, potentially preventing future drug-related cases of heart failure or other worse outcomes, according to a study published today in JACC: Heart Failure.
Malaria, caused by the parasite Plasmodium falciparum, remains one of the main causes of death worldwide. An international team of researchers lead by Instituto Gulbenkian de Ciência, IGC, scientist Carlos Penha-Gonçalves, has identified the first genetic risk factors for the development of cerebral malaria in Angolan children, a severe manifestation of malaria infection.
Amazon Filters reports on how its SupaPore VPBA sterile filter cartridge is enabling a veterinary pharmaceutical manufacturer to process its batches faster while still maintaining the quality of the final products.
The combination of caffeine and glucose can improve the efficiency of brain activity, according to a recent study in which functional magnetic resonance imaging was used to identify the neural substrate for the combined effects of these two substances.
› Verified 7 days ago